Drug Detail

Drug Name Regorafenib
Trade Name Stivarga
Synonyms BAY 73-4506
Drug Descriptions

Stivarga (regorafenib) is an inhibitor of several kinases including VEGFR, RET, KIT, PDGFR and RAF, thereby inhibiting tumor angiogenesis and tumor cell proliferation (PMID: 24756792). Stivarga (regorafenib) is FDA approved for colorectal cancer, hepatocellular carcinoma, and GIST (FDA.gov).

DrugClasses BRAF Inhibitor 18 CRAF Inhibitor 10 KIT Inhibitor 50 PDGFR Inhibitor (Pan) 27 RET Inhibitor 36 VEGFR Inhibitor (Pan) 31 VEGFR2 Inhibitor 34

Filtering

  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"

Sorting

  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Aldoxorubicin + ALT-803 + Avelumab + Capecitabine + Cetuximab + Cyclophosphamide + ETBX-011 + ETBX-021 + ETBX-051 + ETBX-061 + Fluorouracil + GI-4000 + GI-6207 + GI-6301 + haNK cells + Leucovorin + Nab-paclitaxel + Oxaliplatin + Regorafenib + Trastuzumab ALT-803 Aldoxorubicin Avelumab Capecitabine Cetuximab Cyclophosphamide ETBX-011 ETBX-021 ETBX-051 ETBX-061 Fluorouracil GI-4000 GI-6207 GI-6301 Leucovorin Nab-paclitaxel Oxaliplatin Regorafenib Trastuzumab haNK cells 0 1
Azacitidine + Regorafenib Azacitidine Regorafenib 0 1
Capecitabine + Regorafenib Capecitabine Regorafenib 0 1
Capecitabine + Regorafenib + Ruxolitinib Capecitabine Regorafenib Ruxolitinib 0 1
Cetuximab + Regorafenib Cetuximab Regorafenib 3 2
Clobetasol + Regorafenib Clobetasol Regorafenib 0 1
Crizotinib + Regorafenib Crizotinib Regorafenib 1 0
CVX-060 + Regorafenib CVX-060 Regorafenib 0 0
DHA + Regorafenib DHA Regorafenib 1 0
Entinostat + Hydroxychloroquine + Regorafenib Entinostat Hydroxychloroquine Regorafenib 0 1
Fluorouracil + Leucovorin + Oxaliplatin + Regorafenib Fluorouracil Leucovorin Oxaliplatin Regorafenib 0 1
Fluorouracil + Leucovorin + Regorafenib Fluorouracil Leucovorin Regorafenib 0 1
Gemcitabine + Regorafenib Gemcitabine Regorafenib 0 1
Methotrexate + Regorafenib Methotrexate Regorafenib 0 1
MK2206 + Regorafenib + Sorafenib MK2206 Regorafenib Sorafenib 0 0
Napabucasin + Regorafenib Napabucasin Regorafenib 0 1
Nivolumab + Regorafenib Nivolumab Regorafenib 0 1
Panitumumab + Regorafenib Panitumumab Regorafenib 0 1
Pembrolizumab + Regorafenib Pembrolizumab Regorafenib 0 2
Perindopril + Regorafenib Perindopril Regorafenib 0 1
PF-03446962 + Regorafenib PF-03446962 Regorafenib 0 1
Pimasertib + Regorafenib Pimasertib Regorafenib 4 0
Refametinib + Regorafenib Refametinib Regorafenib 0 1
Regorafenib Regorafenib 59 44
Regorafenib + Sorafenib Regorafenib Sorafenib 0 0
Regorafenib + Spartalizumab Regorafenib Spartalizumab 0 1
Regorafenib + Sunitinib Regorafenib Sunitinib 0 0
Regorafenib + trifluridine/tipiracil hydrochloride Regorafenib trifluridine/tipiracil hydrochloride 0 1